Shilian Chen

机构：Guangxi University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University · ORCID：0000-0002-6856-5687

发表论文 37 篇 · 总被引 698 次 · h-index 11

代表论文

• The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data (2017 · Medical Oncology · 被引 177)
• NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma (2020 · Molecular Oncology · 被引 120)
• High COX‐2 expression in cancer‐associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma (2019 · Molecular Carcinogenesis · 被引 81)
• Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma (2020 · British Journal of Haematology · 被引 67)
• Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis (2019 · International Journal of Medical Sciences · 被引 64)
• High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma (2018 · Journal of Cellular Biochemistry · 被引 31)